vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Tectonic Financial, Inc. (TECTP). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $23.0M, roughly 1.9× Tectonic Financial, Inc.). Tectonic Financial, Inc. runs the higher net margin — 23.8% vs -19.9%, a 43.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 17.9%). Tectonic Financial, Inc. produced more free cash flow last quarter ($-17.3M vs $-44.6M). Over the past eight quarters, Tectonic Financial, Inc.'s revenue compounded faster (270.5% CAGR vs 112.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Tectonic Financial, Inc.TECTPEarnings & Financial Report
Tectonic Financial, Inc. is a US-based diversified financial services provider. It offers core services including wealth management, investment banking, capital markets advisory, and tailored financial solutions. Its key client segments cover high-net-worth individuals, institutional investors, and small to mid-sized enterprises across North America.
ABCL vs TECTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $23.0M |
| Net Profit | $-8.9M | $5.5M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 30.6% |
| Net Margin | -19.9% | 23.8% |
| Revenue YoY | 788.4% | 17.9% |
| Net Profit YoY | 73.9% | 15.9% |
| EPS (diluted) | $-0.03 | $0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $9.0M | $23.0M | ||
| Q2 25 | $17.1M | $21.6M | ||
| Q1 25 | $4.2M | $21.8M | ||
| Q4 24 | $5.0M | $21.4M | ||
| Q3 24 | $6.5M | $19.5M | ||
| Q2 24 | $7.3M | $18.6M | ||
| Q1 24 | $10.0M | $17.6M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $5.5M | ||
| Q2 25 | $-34.7M | $4.3M | ||
| Q1 25 | $-45.6M | $4.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-51.1M | $4.7M | ||
| Q2 24 | $-36.9M | $3.1M | ||
| Q1 24 | $-40.6M | $3.1M |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | 30.6% | ||
| Q2 25 | -290.2% | 25.9% | ||
| Q1 25 | -1479.6% | 26.0% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | -1439.4% | 29.1% | ||
| Q2 24 | -1276.2% | 21.5% | ||
| Q1 24 | -551.5% | 22.2% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | 23.8% | ||
| Q2 25 | -203.3% | 19.8% | ||
| Q1 25 | -1077.2% | 20.4% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | -785.4% | 24.2% | ||
| Q2 24 | -504.3% | 16.9% | ||
| Q1 24 | -408.0% | 17.4% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.19 | $0.73 | ||
| Q2 25 | $-0.12 | $0.55 | ||
| Q1 25 | $-0.15 | $0.57 | ||
| Q4 24 | — | $0.35 | ||
| Q3 24 | $-0.17 | $0.58 | ||
| Q2 24 | $-0.13 | $0.38 | ||
| Q1 24 | $-0.14 | $0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $119.2M |
| Total Assets | $1.4B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | — | ||
| Q3 25 | $964.0M | $119.2M | ||
| Q2 25 | $1.0B | $114.6M | ||
| Q1 25 | $1.0B | $111.3M | ||
| Q4 24 | $1.1B | $113.4M | ||
| Q3 24 | $1.1B | $112.8M | ||
| Q2 24 | $1.1B | $110.4M | ||
| Q1 24 | $1.1B | $108.5M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $997.0M | ||
| Q1 25 | $1.3B | $910.5M | ||
| Q4 24 | $1.4B | $863.4M | ||
| Q3 24 | $1.4B | $847.5M | ||
| Q2 24 | $1.4B | $777.1M | ||
| Q1 24 | $1.5B | $777.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-17.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $-17.3M |
| FCF MarginFCF / Revenue | -99.4% | -74.9% |
| Capex IntensityCapex / Revenue | 21.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -3.14× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $-17.3M | ||
| Q2 25 | $-32.4M | $-32.5M | ||
| Q1 25 | $-11.6M | $-35.6M | ||
| Q4 24 | $-108.6M | $-86.6M | ||
| Q3 24 | $-28.9M | $-22.5M | ||
| Q2 24 | $-30.0M | $-30.7M | ||
| Q1 24 | $-41.7M | $-3.2M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $-17.3M | ||
| Q2 25 | $-45.8M | — | ||
| Q1 25 | $-22.2M | $-35.6M | ||
| Q4 24 | $-187.0M | $-86.8M | ||
| Q3 24 | $-47.4M | $-22.5M | ||
| Q2 24 | $-50.1M | $-30.7M | ||
| Q1 24 | $-65.8M | $-3.3M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | -74.9% | ||
| Q2 25 | -267.9% | — | ||
| Q1 25 | -524.0% | -163.2% | ||
| Q4 24 | -3702.8% | -406.5% | ||
| Q3 24 | -728.4% | -115.0% | ||
| Q2 24 | -683.8% | -165.5% | ||
| Q1 24 | -661.5% | -18.8% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 0.0% | ||
| Q2 25 | 78.2% | 0.0% | ||
| Q1 25 | 251.1% | 0.0% | ||
| Q4 24 | 1552.7% | 1.0% | ||
| Q3 24 | 284.6% | 0.1% | ||
| Q2 24 | 274.6% | 0.3% | ||
| Q1 24 | 242.5% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -3.14× | ||
| Q2 25 | — | -7.61× | ||
| Q1 25 | — | -8.00× | ||
| Q4 24 | — | -28.99× | ||
| Q3 24 | — | -4.74× | ||
| Q2 24 | — | -9.76× | ||
| Q1 24 | — | -1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
